Based on the knowledge that activation of the PI3K/Akt pathway results in a decrease in the sensitivity of glioma cells to ionizing radiation, the role of PI3K inhibitors in sensitizing glioma cells to radiotherapy by reducing the cell’s ability to repair DNA damage has been proven [67]. Here, AKT1 is linked to central nervous system cancer.